Blog / Operations

ASC Revenue Cycle Management: Denial Rates, Days in AR and the Benchmarks to Hold

The denial rate, AR and margin benchmarks that separate a 13 percent center from a 37 percent one, and what the 2026 rule changes for billing.

ASC revenue cycle management benchmarks for denial rate, days in AR and EBITDA margin, plus what the 2026 Medicare rule changes for ASC billing.

ASC Revenue Cycle Management: Denial Rates, Days in AR and the Benchmarks to Hold

ASC revenue cycle management starts with two numbers: a denial rate under 5 percent, ideally 1 to 2 percent, and days in accounts receivable under 30, with 72 percent of that balance current rather than aging (SIS, 2019). Most centers do not hit both. The gap between a center that collects cleanly and one that does not shows up nowhere faster than in the EBITDA line, where centers under $3 million in revenue post a 12.8 percent margin and centers over $9 million post 37.3 percent (Avanza).

Margin is not only a scheduling and supply chain story. A denial that takes three weeks to rework, or an AR balance that sits in the 90-day bucket until someone has time to call the payer, is margin leaving the building just as surely as an idle operating room.

Why ASC billing is getting harder, not easier

The CY2026 Medicare rule added 560 procedures to the ASC covered list, 271 of them moved off the inpatient only list, plus 35 ancillary services (CMS, November 2025). Every one of those is a billing problem before it is a revenue opportunity. A newly covered procedure with no established commercial rate is not a payment, it is a negotiation that your billing office and your administrator need to have before the first case is scheduled. The full detail on what changed in the rule, and what to confirm before the CY2027 update, is in The CMS 2026 Final Rule for ASCs: 560 Procedures Added, the Inpatient Only List Phased Out.

The same rule ties a 2.6 percent payment update to the ASC Quality Reporting Program. Centers that do not meet ASCQR requirements lose 2.0 percentage points off their update, not just the increase (CMS). That is a billing office responsibility as much as a clinical one. A missed submission costs the whole year's update, and nobody finds out until the remittance advice arrives lower than expected.

The two numbers that define the revenue cycle

Denial rate is claims denied on first submission divided by claims sent. The benchmark is under 5 percent, with 1 to 2 percent as the practical target (SIS, 2019). Most denials trace back to eligibility and authorization problems that start at booking, which means the first fix belongs at the front desk, not in the billing department three weeks later.

Days in accounts receivable is receivables divided by average daily net revenue. The benchmark is under 30 days, and SIS found that well-run centers keep 72 percent of that balance current rather than aging in the ledger (SIS, 2019). A center that hits the 30-day average on paper but has half its AR sitting past due has a collections problem the headline number hides. Measure both the average and the distribution, every month, the same way.

ASC billing and revenue cycle benchmarks (SIS, 2019; CMS, November 2025)
MetricBenchmark
Denial rateUnder 5%, ideally 1 to 2%
Days in accounts receivableUnder 30 days, with 72% current
EBITDA margin, under $3M revenue12.8%
EBITDA margin, over $9M revenue37.3%
Payment update for compliant ASCQR reporting, 2026+2.6%
Payment reduction for missed ASCQR reporting-2.0 percentage points
Procedures added to ASC covered list for 2026560, including 271 from the inpatient only list

Where denials actually start

A cancellation inside 24 hours is both a clinical event and a billing event. The slot rarely refills, and the claim never gets filed at all. OR Manager puts the ASC cancellation rate near 1 percent against 1.7 percent in hospitals, and pre-admission testing and insurance verification earlier in the scheduling window close most of that gap (OR Manager). The same schedule discipline that protects block utilization and first-case starts protects the revenue cycle too. A detailed list of the schedule metrics worth tracking alongside denial rate and AR is in Operating Room KPIs: The Key Performance Indicators Surgical Services Directors Track.

Supply and implant pricing also show up downstream in billing, through underpayment on cases where the contracted rate never matched the actual cost of the implant. Getting consumption and pricing data right at the case level, the subject of ASC Inventory Management: A Six-Step Method and the Numbers to Track, is as much a revenue cycle input as a supply chain one.

Site neutrality and the new commercial rate conversation

Most commercial payers price ASC procedures as a multiple of the Medicare rate, which means every new covered procedure from the 2026 list needs its own rate conversation rather than a blanket percentage applied by default. Medicare's own direction is toward site neutral payment, paying the same rate for the same service regardless of where it happens, and hospital outpatient rates are generally higher than ASC rates for the same procedure today (MedPAC). That gap is the ASC's negotiating position, not a policy footnote to skip past. The full mechanics are in Site Neutral Payments Explained for ASC Owners and Hospital CFOs.

Walking into that conversation with cost per case data, by procedure and by payer, is what separates an owner who improves a contract from one who accepts the renewal as written. The ten operating and financial benchmarks that feed that conversation, from block utilization through EBITDA margin, are laid out in ASC Benchmarks 2027.

Management fees and outsourced billing

Centers that outsource billing to a management company commonly pay a management fee in the range of 4 to 7 percent of net revenue, in addition to an equity stake, a figure widely reported across the industry (industry convention, commonly reported). That fee needs to be measured against what it buys. A denial rate and days in AR that beat the SIS benchmarks are worth the fee. A monthly report that cannot show either number, broken out the way they are defined above, is buying activity rather than results, and that is worth asking about at the next contract renewal.

What to do this quarter

  1. Pull denial rate and days in AR for the last three months, by payer, and compare them to the SIS benchmark of under 5 percent and under 30 days, with 72 percent current (SIS, 2019).
  2. List every procedure your surgeons intend to add under the 2026 covered list and mark which payers have an actual commercial rate attached versus which ones require a new negotiation.
  3. Confirm your center's ASCQR submission is complete before year end, so the 2.6 percent update is not cut by 2.0 points for a missed report (CMS).

Make your ASC more profitable

Sigmatic is a team of ASC consultants who use our own technology to manage surgery centers: better margins, better workflows, and a real-time view of cost per case and utilization that keeps the gains in place. If the numbers in this article look like your center, book a free 30-minute consultation and we will go through your own figures and show you where the margin is. Read the ASC Benchmarks 2027 guide, grab the free PDF, The 2027 ASC State of the Union: maximizing profit on razor-thin margins, from the form on this page, or email [email protected].

Free guide

The 2027 ASC State of the Union: Maximizing profit on razor-thin margins

16 pages of charts: the market, the 2026 reimbursement rules, the benchmarks that separate a 13 percent margin from a 37 percent one, a case costing method you can run this month and a 90-day plan.

One email with the PDF, then the occasional note on ASC margins. Unsubscribe any time.

Before you go

Want a more profitable ASC?

Book a free 30-minute consultation on your own numbers, or leave your email and we will send the 2027 guide first.

Make your ASC more profitable.

A free 30-minute consultation on your own numbers: where the margin is, what to fix first. No obligation.